Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Tetracaine hydrochloride 20 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 20 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 20 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 5 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 1% injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 10mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 5mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 3mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amethocaine adverse reaction |
Causative agent (attribute) |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amethocaine hydrochloride 2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amethocaine hydrochloride 1% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amethocaine hydrochloride 0.5% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzocaine + butamben + tetracaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 0.3%/dextrose 6% injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 0.2%/dextrose 6% injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amethocaine hydrochloride 1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amethocaine hydrochloride 0.5% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 10 mg/g cutaneous cream |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 10 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 20 mg/mL cutaneous cream |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 20 mg/mL cutaneous cream |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 5 mg/mL cutaneous solution |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 5 mg/mL cutaneous solution |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 20 mg/g cutaneous gel |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 20 mg/g cutaneous gel |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 20 mg/mL cutaneous solution |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 20 mg/mL cutaneous solution |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 10 mg/mL eye solution |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Tetracaine hydrochloride 10 mg/mL eye solution |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
Has precise active ingredient |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
Has basis of strength substance (attribute) |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
Has precise active ingredient |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
Has basis of strength substance (attribute) |
False |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has precise active ingredient |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Has basis of strength substance (attribute) |
True |
Tetracaine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |